165 related articles for article (PubMed ID: 23016149)
1. Magnetic-Fe/Fe(3)O(4)-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages.
Wang H; Shrestha TB; Basel MT; Dani RK; Seo GM; Balivada S; Pyle MM; Prock H; Koper OB; Thapa PS; Moore D; Li P; Chikan V; Troyer DL; Bossmann SH
Beilstein J Nanotechnol; 2012; 3():444-55. PubMed ID: 23016149
[TBL] [Abstract][Full Text] [Related]
2. A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model.
Basel MT; Balivada S; Shrestha TB; Seo GM; Pyle MM; Tamura M; Bossmann SH; Troyer DL
Small; 2012 Mar; 8(6):913-20. PubMed ID: 22238072
[TBL] [Abstract][Full Text] [Related]
3. A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
Seo GM; Rachakatla RS; Balivada S; Pyle M; Shrestha TB; Basel MT; Myers C; Wang H; Tamura M; Bossmann SH; Troyer DL
Mol Biol Rep; 2012 Jan; 39(1):157-65. PubMed ID: 21567204
[TBL] [Abstract][Full Text] [Related]
4. Macrophages Loaded with Fe Nanoparticles for Enhanced Photothermal Ablation of Tumors.
Yu L; Zhu S; Qin K; Fan X; An L
J Funct Biomater; 2022 Jul; 13(3):. PubMed ID: 35893461
[TBL] [Abstract][Full Text] [Related]
5. Two-Stage SN38 Release from a Core-Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade.
Jiang X; Lee M; Xia J; Luo T; Liu J; Rodriguez M; Lin W
ACS Nano; 2022 Dec; 16(12):21417-21430. PubMed ID: 36382721
[TBL] [Abstract][Full Text] [Related]
6. Targeted Delivery of DNA Topoisomerase Inhibitor SN38 to Intracranial Tumors of Glioblastoma Using Sub-5 Ultrafine Iron Oxide Nanoparticles.
Li Y; Xie M; Jones JB; Zhang Z; Wang Z; Dang T; Wang X; Lipowska M; Mao H
Adv Healthc Mater; 2022 Jul; 11(14):e2102816. PubMed ID: 35481625
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model.
Nguyen F; Alferiev I; Guan P; Guerrero DT; Kolla V; Moorthy GS; Chorny M; Brodeur GM
Clin Cancer Res; 2018 Jun; 24(11):2585-2593. PubMed ID: 29514842
[No Abstract] [Full Text] [Related]
8. Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer.
Xue T; Xu P; Padelford J; Xue X; Wu AY; Li Y; Wang L
Invest New Drugs; 2022 Jun; 40(3):546-555. PubMed ID: 35290548
[TBL] [Abstract][Full Text] [Related]
9. "Sweet tooth"-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy.
Ding N; Xu S; Zheng S; Ye Q; Xu L; Ling S; Xie S; Chen W; Zhang Z; Xue M; Lin Z; Xu X; Wang L
J Mater Chem B; 2021 Mar; 9(12):2816-2830. PubMed ID: 33690741
[TBL] [Abstract][Full Text] [Related]
10. Enhanced specific absorption rate in silanol functionalized Fe3O4 core-shell nanoparticles: study of Fe leaching in Fe3O4 and hyperthermia in L929 and HeLa cells.
Majeed J; Pradhan L; Ningthoujam RS; Vatsa RK; Bahadur D; Tyagi AK
Colloids Surf B Biointerfaces; 2014 Oct; 122():396-403. PubMed ID: 25089699
[TBL] [Abstract][Full Text] [Related]
11. Glutamic acid-coated Fe
Dutta B; Nema A; Shetake NG; Gupta J; Barick KC; Lawande MA; Pandey BN; Priyadarsini IK; Hassan PA
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110915. PubMed ID: 32409067
[TBL] [Abstract][Full Text] [Related]
12. Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation.
He W; Du Y; Wang T; Wang J; Cheng L; Li X
Int J Pharm; 2021 Sep; 606():120856. PubMed ID: 34229071
[TBL] [Abstract][Full Text] [Related]
13. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
14. A multi-stimuli responsive nanoparticulate SN38 prodrug for cancer chemotherapy.
Liu X; Huang Q; Yang C; Zhang Q; Chen W; Shen Y; Sui M
J Mater Chem B; 2017 Jan; 5(4):661-670. PubMed ID: 32263833
[TBL] [Abstract][Full Text] [Related]
15. Albumin-Gold Nanorod Nanoplatform for Cell-Mediated Tumoritropic Delivery with Homogenous ChemoDrug Distribution and Enhanced Retention Ability.
Chiu HT; Su CK; Sun YC; Chiang CS; Huang YF
Theranostics; 2017; 7(12):3034-3052. PubMed ID: 28839462
[TBL] [Abstract][Full Text] [Related]
16. Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies.
Wang Y; Xie H; Ying K; Xie B; Chen X; Yang B; Jin J; Wan J; Li T; Han W; Fang S; Wang H
Biomaterials; 2021 Mar; 270():120705. PubMed ID: 33581609
[TBL] [Abstract][Full Text] [Related]
17. Macrophages as an active tumour-targeting carrier of SN38-nanoparticles for cancer therapy.
Huang Z; Sun X; Liu X; Shen Y; Wang K
J Drug Target; 2018; 26(5-6):458-465. PubMed ID: 29251524
[TBL] [Abstract][Full Text] [Related]
18. Effects of PEGylated Fe-Fe
Domac BH; AlKhatib S; Zirhli O; Akdogan NG; Öçal Dirican ŞC; Bulut G; Akdogan O
Heliyon; 2020 Jan; 6(1):e03124. PubMed ID: 31909281
[TBL] [Abstract][Full Text] [Related]
19. CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer.
Alibolandi M; Abnous K; Anvari S; Mohammadi M; Ramezani M; Taghdisi SM
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1159-1169. PubMed ID: 29519158
[TBL] [Abstract][Full Text] [Related]
20. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
